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ABSTRACT 
Author: Davis, Kymeri, E. MS 
Institution: Purdue University 
Degree Received: August 2019 
Title: Detection of Illicit Drugs in Various Matrices via Total Vaporization Solid-Phase 
Microextraction (TV-SPME) 
Major Professor: John Goodpaster 
 
In Headspace Solid-Phase Microextraction (Headspace SPME), a sample is heated to 
encourage a portion of the analyte into the headspace of a vial. A coated fiber is introduced into 
the sample headspace and the analyte is adsorbed onto the fiber coating. Total Vaporization Solid-
Phase Microextraction (TV-SPME) is a technique that is derived from this technique. In TV-SPME, 
liquid samples are completely vaporized allowing for better adsorption and fewer matrix effects. 
This method does not require any sample preparation, utilizes minimal supplies and can be 
automated, making it both an efficient and cost-effective method. Chapter 1 will discuss the theory 
of SPME and TV-SPME. 
In Chapter 2, the detection of ɣ-hydroxybutyric acid (GHB) and ɣ-butyrolactone (GBL) in 
beverages is discussed. The detection of these compounds in beverages is of importance because 
these drugs may be used to facilitate sexual assault. This crime utilizes substances that cause 
sedation and memory loss. The derivatization of GHB as well as the properties that make GHB 
difficult to detect will be discussed.  
Chapter 3 will discuss the detection of methamphetamine and amphetamine (as their 
trifluoroacetyl derivatives), GBL, and the trimethylsilyl derivative of GHB in human urine. 
Amphetamine is a metabolite of methamphetamine, therefore, both drugs should be identified 
within biological samples. GHB and GBL are metabolites of one another and interconvert when 
in aqueous solution. This interconversion will be discussed.  
12 
Chapter 4 will cover method optimization of the Total Vaporization Solid-Phase 
Microextraction method. Analytes of interest for these analyses were methamphetamine, 
amphetamine, GHB, and GBL. The optimal extraction temperature ranging from 60-160°C of each 
drug will be discussed as well as why higher temperatures may not be suitable for this method. A 
limit of detection study for methamphetamine and amphetamine will also be covered.  
Chapter 5, the future work chapter, will discuss future analyses using the Total Vaporization 
Solid-Phase Microextraction method including the analysis of powder materials, plant material, 
and toxicological samples. Powder material will include the analysis of individual powdered drugs 
as well as realistic drug mixtures. Some analyses on individual powder samples has already been 
completed and will be shown. Plant material will include the analysis of naturally occurring 
compounds found in marijuana plants as well as synthetic cannabinoids. Toxicological samples 
will expand on previously mentioned urine samples to include drugs such as benzoylecgonine and 
THC-COOH.  
 
13 
CHAPTER 1. TOTAL VAPORIZATION SOLID-PHASE 
MICROEXTRACTION OVERVIEW 
Introduction 
While Gas Chromatography – Mass Spectrometry (GC-MS) is a frequently used technique 
in forensic science laboratories, it has limitations such as the need for compounds to be thermally 
stable as well as volatile1. Some compounds must undergo derivatization prior to being injected 
into the gas chromatograph (GC) to satisfy these requirements. Headspace Solid-Phase 
Microextraction (SPME) is a technique in which a sample is placed into a vial and the vial is 
heated to encourage a portion of the analyte to vaporize into the headspace. A SPME fiber, 
coated with a polymeric material such as polydimethylsiloxane-divinylbenzene (PDMS/DVB) is 
then introduced into the sample headspace and the analyte is adsorbed onto the fiber meaning 
that the analyte forms a thin coating on the fiber. The fiber is then placed inside the GC inlet for 
desorption. 
Total Vaporization Solid-Phase Microextraction (TV-SPME) relies on the same technique 
as headspace SPME but completely vaporizes a liquid sample before being adsorbed onto the 
fiber. This allows for partitioning of the analyte between only the vapor and the coating of the 
fiber. With this approach, more of the sample is adsorbed onto the fiber and small sample sizes 
(e.g. 1 – 100 µL) may be used. This method also helps to eliminate matrix effects due to this 
being a two-phase system as opposed to a three-phase system like standard headspace SPME. 
TV-SPME is like immersion SPME in that immersion SPME is also a two-phase system.1 With 
immersion SPME, a fiber is immersed into a liquid sample containing the analyte as opposed to 
extracting the analyte from its vapor. TV-SPME is preferred to immersion SPME because 
immersion SPME requires more sample volume than TV-SPME.  
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To perform TV-SPME, analytes are dissolved in a solvent and an aliquot of this mixture is 
placed into a 20 mL headspace GC vial. Specific volumes of liquid samples must be used in 
order to ensure total vaporization of the sample. These volumes are determined by using the 
Ideal Gas Law to calculate the number of moles of a solvent multiplied by the molar volume of 
the liquid (Equation 1). 
 
𝑉𝑜 = (
𝑃𝑉𝑣
𝑅𝑇
) (
𝑀
⍴
)    Equation 1 
 
where Vo is the volume of the sample (mL), P is the vapor pressure of the solvent (bar), Vv is the 
volume of the vial (L), R is the ideal gas constant (0.083145 
(𝐿∗𝑏𝑎𝑟)
𝑘∗𝑚𝑜𝑙
), M is the molar mass of the 
solvent (g/mol), T is temperature (K), and ⍴ is the density of the solvent (g/mL)2.  
 The Antoine equation (Equation 2) is used to account for the influence of temperature on 
vapor pressure: 
 
𝑙𝑜𝑔10𝑃 = 𝐴 − (
𝐵
𝑇+𝐶
)     Equation 2 
 
where T is temperature and A, B, and C are the Antoine constants for the solvent. Equation 2 
may be substituted into Equation 1, yielding: 
 
𝑉𝑜 = (
(10
𝐴−
𝐵
𝑇+𝐶)𝑉𝑣
𝑅𝑇
)(
𝑀
⍴
)    Equation 3 
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Equation 3 gives the volume of the sample (Vo) that can be completely vaporized as a function of 
the temperature and solvent used.2 
Derivatization may also take place during this procedure. When derivatization is needed 
for a GC method, a labile hydrogen on an analyte is replaced with a functional group that allows 
for better separation by making the analyte thermally stable and more volatile. There are three 
forms of derivatization: acylation, silylation and alkylation. For this work, acylation and 
silylation were performed. The derivatization agent used for acylation was trifluoroacetic 
anhydride (TFAA). A general reaction of TFAA with an amine is shown in Figure 1. To perform 
silylation, N,O-bis (trimethylsilyl) trifluoroacetamide (BSTFA) + 1% trimethylchlorosilane 
(TMCS) was used to derivatize carboxylic acids and amines. A general reaction for BSTFA + 
1% TMCS is shown in Figure 2. 
Figure 1. General reaction for TFAA with an amine.  
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Figure 2. General reaction for BSTFA + 1% TMCS where X can be either an oxygen or a 
nitrogen atom.  
 
To perform derivatization with TV-SPME, the SPME fiber is first exposed to a vial 
containing the derivatization agent for a predetermined amount of time depending on the analyte. 
The SPME fiber is then exposed to a new vial containing the analyte of interest. This vial is 
heated inside of a heated agitator. The analyte is then adsorbed onto the fiber with the 
derivatization agent. The derivatization of the analyte and/or the matrix takes place on the fiber 
before being inserted into the GC inlet for desorption. The derivatization vial was kept at room 
temperature when TFAA was used and the vial is heated when BSTFA + 1% TMCS was used. 
This is because TFAA evaporates much more quickly than BSFTA + 1% TMCS. A depiction of 
TV-SPME may be seen in Figure 3 below. 
 
Figure 3. Depiction of the TV-SPME procedure2. 
17 
TV-SPME is beneficial because it allows for the analyte to be derivatized during the 
extraction process which reduces analysis time. Other methods, such as liquid injection, require 
that the analyte react with the derivatizing agent in solution prior to being injected into the GC. 
TV-SPME also requires little to no sample preparation. A matrix containing an analyte may be 
placed directly into the headspace vial and analyzed. Extraction procedures are not necessary 
because any nonvolatile compounds will remain in the headspace vial and will not be adsorbed 
onto the fiber. This method also utilizes small sample sizes. Most sample volumes range from 
2.4 µL – 24 µL depending on the solvent used. Currently, TV-SPME is a qualitative technique 
and not quantitative. 
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CHAPTER 2. DETERMINATION OF Ɣ-HYDROXYBUTYRIC ACID & Ɣ-
BUTYROLACTONE IN ALCOHOLIC BEVERAGES 
Introduction 
ɣ-Hydroxybutyric acid (GHB) and ɣ-butyrolactone (GBL), seen in Figure 4 are 
compounds that may be found in cases of drug facilitated sexual assault (DFSA). DFSA occurs 
when one person uses a drug to incapacitate an individual and then proceeds to commit a sexual 
assault. This may be done by intentionally giving the victim the drug without their knowledge or 
if the victim has self-administered the drug and therefore was incapable of giving consent. GHB 
and GBL are ideal drugs for DFSA because they cause sedation, short-term memory loss, and are 
quickly metabolized in the body. GHB and GBL are colorless, odorless, and are often tasteless. 
GHB is a Schedule I drug and is often produced in domestic and foreign clandestine laboratories. 
GBL is a List 1 chemical and is sold as an industrial product such as fish tank cleaner.3 A List 1 
chemical is a regulated chemical that can be used to manufacture an illegal substance.4 DFSA is 
underreported because victims may not be aware that they were assaulted due to memory loss 
caused by the drug. While it is not known how many DFSA occurrences happen each year, the 
United States Department of Justice states that these occurrences are increasing.5 
 
(a)                                                      (b) 
Figure 4. Molecular structure for a) GHB (104.1 g/mol) and b) GBL (86 g/mol).  
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GHB has a half-life of 30-50 minutes in the human body.6 Exogenous GHB is cleared from 
the blood stream within 5 hours and from urine within 3-10 hours.6, 7 GBL also has a short half-
life of 30-52 minutes within the body.8 The detection of exogenous GHB is difficult because it is 
a naturally occurring compound in mammals.6 When biological samples suspected of containing 
GHB are tested, a clean sample of the alleged victim’s urine must also be collected to account for 
their naturally occurring GHB levels. This means that an additional sample must be collected 
from the alleged victim roughly 12 hours after an attack has occurred. Therefore, the detection of 
GHB and GBL in suspected beverages is highly important as it gives a more reliable 
concentration of the exogenous drug used. 
Gas Chromatography - Mass Spectrometry (GC-MS) is commonly used for the detection 
of GHB and GBL. GHB may be found in hair, blood, and urine.9, 10 Other methods used to detect 
GHB include High Performance Liquid Chromatography, Liquid Chromatography-MS, 
Headspace Solid-phase Microextraction, and Nuclear Magnetic Resonance Spectroscopy. Solid 
samples of GHB and GBL may be analyzed using Infrared Spectroscopy. GBL may be detected 
using GC-MS and Raman Spectroscopy may be used to detect GHB and GBL simultaneously.11-
13 Unlike TV-SPME, Raman Spectroscopy analysis cannot be automated because it requires 
manual adjustment to view the sample. GHB is often detected with GBL so these methods 
require an extraction step which can be time consuming and labor intensive.14 TV-SPME does 
not require any sample preparation and GHB and GBL may be analyzed simultaneously. 
GHB cannot be detected by GC-MS methods “as is” due to its hydrophilicity via the two 
hydroxyl groups on either end of the molecule and its thermal instability. A compound must be 
stable at temperatures at or above 200°C.1 Therefore, derivatization of the compound must be 
performed. GHB is a carboxylic acid so N,O-bis (trimethylsilyl) trifluoroacetamide  (BSTFA) + 
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1% trimethylchlorosilane (TMCS) may be used to derivatize GHB into ɣ-hydroxybutyric acid-
trimethylsilyl2 (GHB-TMS2), producing a more stable compound that may be detected by GC-
MS methods. The reaction of BSFTA + 1% TMCS with GHB is shown in Figure 5. GBL does 
not require derivatization to be detected by the GC, however, when spiked into beverages with a 
high concentration of water, such as alcoholic beverages, derivatization of the aqueous matrix is 
needed to achieve the desired results. This is because water in not an ideal solvent for GC 
analysis due to its high vapor pressure. Therefore, the GBL samples were also derivatized with 
BSTFA + 1% TMCS to derivatize the water in the matrix. The derivatization agent does not 
affect the GBL compound.  
 
Figure 5. Reaction of GHB with BSTFA + 1% TMCS to form GHB-TMS2. 
 
GHB and GBL may be spiked into any beverage but are often spiked into alcoholic 
beverages at parties, raves, or night clubs without the victim’s knowledge. Beer, wine, and liquor 
are the most commonly consumed beverages within these settings. For this work, water, beer, 
wine, and rum and Coke© were spiked with GHB and beer, wine, and rum were spiked with GBL 
and analyzed using the TV-SPME GC-MS method. GHB is very soluble in water and alcohol.15 
Both GHB and GBL will cause sedation when 2 - 3 g is ingested.16,17 The standard 
alcoholic beverage is 150 mL.17 Therefore, a beverage spiked with 2.5 g of GHB or GBL would 
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have a concentration of about 16 mg/mL. For these analyses, lower concentrations of 8 mg/mL 
of GHB and 10 mg/mL of GBL were used.  
Experimental 
Materials  
GHB was purchased from Cayman Chemical (Ann Arbor, Michigan) and GBL was 
purchased from Sigma-Aldrich (Saint Louis, Missouri). BSTFA + 1% TMCS was purchased 
from Thermo Fisher Scientific (Waltham, Massachusetts). Polydimethyl siloxane divinylbenzene 
SPME fibers, 65 µm film thickness, were purchased from Supelco (Bellefonte, Pennsylvania). 
The matrices, beer, wine, rum, and Coke© were purchased from local grocery stores.  
Sample Preparation 
GHB was spiked into water, beer, wine, and rum and Coke© with 8 mg/mL 
concentrations by placing 0.5 mg into a vial along with 62.5 µL of the matrix. From these 
samples, 2.4 µL was placed into a 20 mL headspace vial. GBL was spiked into a sample of beer, 
wine, and rum by placing 8.8 µL of GBL into 1 mL of each solvent for a final concentration of 
10 mg/mL. From these solutions, 2.4 µL of each were placed into a 20 mL headspace vial. The 
PDMS/DVB fiber was first exposed to the vial containing BSFTA + 1% TMCS for 50 minutes 
for GHB and 10 minutes for GBL before being inserted into the vial containing the sample for 10 
minutes. The fiber was then inserted into the GC inlet for desorption at 250°C.  
GC-MS Parameters 
An Agilent 6890N GC coupled with an Agilent 5975 inert Mass Selective Detector with an 
attached Gerstel PAL RTC Multi-Purpose Sampler (MPS) was used for all experiments. The GC 
22 
column was an Agilent Technologies DB-5MS column, 30 m long, 0.25 mm inner diameter, 0.25 
µm film thickness. 
The GC inlet was set to 250ºC and was in splitless mode. The initial oven temperature was 
60ºC and was held for 1 minute. The temperature was then ramped to 250ºC at 15ºC/min and 
held for 1 minute at the final temperature. The mass transfer line was set to 250ºC and the flow 
rate was kept at 2.5 mL/min. The source was held at 230ºC and the quadrupoles were held at 
150ºC. The mass range scanned was m/z 40 - m/z 550. Total ion chromatograms (TIC) were 
generated and extracted ion profiles were used to identify the analyte of interest in each sample. 
All compounds were identified using the SWGDRUG and/or NIST libraries.  
Results and Discussion 
GHB in Beverages 
The GHB-TMS2 chromatogram for GHB in water is shown in Figure 6. The 
corresponding fragmentation and mass spectrum are shown in Figure 7 below. The m/z 147 ion 
peak is a fragment of the derivatization agent, BSTFA. It is formed when a compound contains 
two functional groups such as the carboxylic acid and alcohol in GHB. GHB was detected in 
water, beer, wine, and rum and Coke© with concentrations of 8 mg/mL. The chromatograms for 
each spiked beverage are shown in Figures 8-10.  
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Figure 6. Total Ion Chromatogram (TIC) of GHB-TMS2 (molecular weight: 248 g/mol) in water 
with an 8 mg/mL concentration. 
 
a.                                                                              b.  
Figure 7. Ion fragmentation (a) and mass spectrum (b) for GHB-TMS2
 in water (8 mg/mL).  
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1. GHB-TMS2 
2. Octanoic acid ester-TMS 
3. Glycerol-TMS3 
4. Nonanoic acid ester-TMS 
* = Siloxane  
 
Figure 8. TIC of GHB-TMS2 in beer with an 8 mg/mL concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.Trimethyl(2-phenylethoxy) silane 
2. GHB-TMS2 
3. Ethyl succinate-TMS 
4. Octanoic acid ester-TMS 
5. Nonanoic acid ester-TMS 
* = Siloxane 
 
Figure 9. TIC of GHB-TMS2 in wine with an 8 mg/mL concentration. 
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1. GHB-TMS2 
2. Octanoic acid ester-TMS 
3. Nonanoic acid ester-TMS 
* = Siloxane 
 
Figure 10. TIC of GHB-TMS2 in rum and Coke
© with an 8 mg/mL concentration. 
 
GBL in Beverages  
Like GHB, GBL may also be used in DFSA due to its sedative effects. GBL has a short 
half-life in the body and therefore cannot be detected in a biological sample shortly after 
ingestion. GBL can, however, be detected in beverages including beer, wine, and rum. The GBL 
in beer chromatogram is shown in Figure 11 and the GBL mass spectrum and fragmentation are 
shown in Figures 12 and 13 respectively. GBL was detected in beer, wine, and rum with 
concentrations of 10 mg/mL. The additional chromatograms for each spiked beverage are shown 
in Figures 14 and 15. 
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1. GBL 
2. Hexanoic acid-TMS 
3. Trimethyl(2-phenylethoxy) silane 
4. GHB-TMS2 
5. Benzoic acid ester-TMS 
6. Octanoic acid ester-TMS 
7. Nonanoic acid ester-TMS 
* = Siloxane 
 
Figure 11. TIC of GBL in beer (10 mg/mL). 
Figure 12. Mass spectrum for GBL in beer. 
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           a.       b.   c. 
Figure 13. Ion fragments of GBL a) m/z 42, b) m/z 57, and c) m/z 87.  
 
 
 
1. GBL 
2. Hexanoic acid ester-TMS 
3. Trimethyl(2-phenylethoxy) silane 
4. GHB-TMS2 
5. Octanoic acid ester-TMS 
6. Nonanoic acid ester-TMS 
* = Siloxane 
 
Figure 14. TIC for GBL in wine (10mg/mL). 
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1. GBL 
2. Hexanoic acid ester-TMS 
3. 2-Propenyl ester hexanoic acid 
4. α-Terpineol 
5. GHB-TMS2 
6. Octanoic acid ester-TMS 
7. Nonanoic acid ester-TMS 
* = Siloxane 
 
Figure 15. TIC for GBL in rum (10 mg/mL).  
 
The samples GHB and GBL in beer, wine, and rum contained GBL, GHB-TMS2, 
siloxanes, as well as various additional compounds. These additional compounds, along with 
their structure are shown in Table 1 below.  
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Table 1. Names and structures for compounds found in the GHB and GBL samples. 
Compound Structure 
Derivative 
of  
Hexanoic acid-
TMS 
 
Hexanoic 
acid 
Trimethyl(2-
phenylethoxy) 
silane 
 
Phenethyl 
alcohol 
Benzoic acid 
ester-TMS 
 
 
Benzoic acid 
Octanoic acid 
ester-TMS 
 
Caprylic 
acid 
Nonanoic acid-
TMS 
 
 
Nonanoic 
acid 
α-Terpineol 
 
NA 
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Compound Structure 
Derivative 
of  
Glycerol-TMS 
 
Glycerol 
Ethyl succinate-
TMS 
 
Monoethyl 
succinate 
 
 
Hexanoic acid, phenethyl alcohol, benzoic acid, caprylic acid, nonanoic acid, and 
glycerol are compounds that are found in alcoholic beverages. These compounds are formed 
during the fermentation process.18-22 Phenethyl alcohol is an alcohol that comes from the grapes 
used in wine.21 Nonanoic acid, 2-propenyl ester hexanoic acid, and α-terpineol are compounds 
used as flavoring agents.23-25 Monoethyl succinate is a compound found in wines that is formed 
during fermentation.26 These compounds were found in the spiked beverage samples. Many 
siloxane peaks were also identified. These siloxanes are due to the degradation of the coating on 
the PDMS/DVB SPME fiber. These compounds tend to become more abundant when high 
temperatures are used. 
Conclusion 
GHB may be used to facilitate sexual assault as it causes memory loss and incapacitation. 
GHB can be a difficult analyte to detect in biological samples due to it being a naturally 
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occurring compound in humans as well as its short half-life. Therefore, detection in beverages 
suspected of containing GHB is of high importance. GHB can be detected in beverages including 
water, beer, wine, and rum and Coke©.  
Several of the GHB peaks were “flat-topped” and the GBL peaks exhibited fronting. The 
poor peak shape could be caused by the high concentration of GHB and GBL in solution. These 
issues should be considered when real life samples are analyzed. Resolutions for these issues 
could be diluting the sample, using a split-injection ratio, decreasing the extraction time or 
temperature, or decreasing the desorption time.  
Overall, the performance of this TV-SPME GC-MS method was acceptable for the 
detection of GHB and GBL in beverages. Sample preparation, aside from possible dilutions, is 
not needed to perform this method. 
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CHAPTER 3. DETERMINATION OF AMPHETAMINES, GHB, & GBL 
IN HUMAN URINE 
Introduction 
Urine is the most common biological sample used to determine drug use. This is because it 
is a relatively non-invasive sample to collect and most drugs can be detected in urine.27,28 For 
this work, parent drugs as well as their metabolites were screened for in human urine. The drugs 
of interest were methamphetamine and amphetamine (Figure 16), as well as GHB and GBL 
(Figure 4). 
Methamphetamine & Amphetamine 
Methamphetamine is a central nervous system (CNS) stimulant that is highly addictive.3 
Methamphetamine is a Schedule II drug that may be prescribed to treat obesity or attention 
deficit hyperactivity disorder (ADHD).3 Illegal methamphetamine is supplied to the United 
States through Mexican drug trafficking organizations as well as through domestic clandestine 
operations.3 It is often in the form of a white or off-white powder that may be snorted, injected, 
or smoked. 
Amphetamine may also be used as a CNS stimulant. Amphetamine may be prescribed to 
treat narcolepsy and ADHD3. Amphetamine is a highly addictive Schedule II drug that comes in 
the form of tablets or powders. It may be taken orally or intravenously.3 Both methamphetamine 
and amphetamine are eliminated from the body in urine. In addition, some methamphetamine is 
metabolized by the user into amphetamine. Methamphetamine is eliminated from urine within 3-
6 days and from blood within 24-72 hours.29  
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Although there are many biological samples that may be analyzed for methamphetamine 
and amphetamine (e.g., hair, nail clippings, urine, plasma, and oral fluid), urine remains a 
popular, reliable, and convenient biological sample.30-32 
 
 
(a)                                                              (b) 
Figure 16. Structures of the phenylethylamines analyzed: a) methamphetamine (149.2 g/mol) and 
b) amphetamine (135.2 g/mol). 
 
Methamphetamine and amphetamine may be identified using various techniques and 
methods including numerous SPME techniques. These techniques and methods are shown in 
Table 2 below.  
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Table 2. Various techniques used for the detection of methamphetamine and amphetamine. 
Analyte Matrix/Solvent Technique 
Methamphetamine Acidified iodoplatinate solution Thin-Layer Chromatography 
(TLC)33 
Methamphetamine Chloroform GC33 
Methamphetamine Methanol HPLC33 
Amphetamine 1% Ninhydrin in methanol TLC34 
Amphetamine Chloroform:Methanol 4:1 GC34 
Amphetamine 0.1 Normal hydrochloric acid HPLC34 
Methamphetamine Urine SPME/GC-MS35 
Electroenhanced (EE) SPME/GC-
MS36 
SPME-GC37, 38 
Methamphetamine/
Amphetamine 
Urine SPME/GC-MS39-48 
SPME/GC-Nitrogen Phosphorous 
Detector (NPD)49 
Direct-Immersion SPME/GC-NPD50 
SPME/LC-MS51 
SPME/LC52 
SPME/LC-Electrospray Ionization 
(ESI)-MS53 
SPME-GC54 
SPME/High-Field Asymmetric 
Waveform Ion Mobility 
Spectrometry/ESI/MS55 
SPME/GC-Flame Ionization 
Detection56 
SPME/GC-NPD/GC-MS57 
SPME/Capillary Zone 
Electrophoresis58 
EE-SPME/GC59 
Methamphetamine/
Amphetamine 
Urine/Hair SPME/GC-MS60 
SPME/HPLC-ESI-MS61 
Methamphetamine Urine/Water SPME/GC-MS62 
Methamphetamine/
Amphetamine 
Urine/Serum SPME/GC-MS63 
Methamphetamine Urine/Oral Fluid SPME-Transmission Mode/Direct 
Analysis in Real Time-MS/MS64 
Methamphetamine/
Amphetamine 
Hair SPME/GC-MS65 
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Methamphetamine and amphetamine are amines and may be derivatized with 
trifluoroacetic anhydride (TFAA). Methamphetamine does not have to be derivatized to be 
detected by the GC, however, derivatization will improve this detection as the volatility of the 
compound will increase. The reaction of TFAA with methamphetamine is shown in Figure 17 
and with amphetamine in Figure 18.  
Figure 17. Reaction of methamphetamine with TFAA to form methamphetamine-TFA. 
 
Figure 18. Reaction of amphetamine with TFAA to form amphetamine-TFA.  
GHB & GBL 
GHB and GBL will interconvert when in solution. Therefore, GHB and GBL are likely 
consumed together and will both be excreted from the body in urine. GHB is a hydroxylated 
short chain fatty acid and GBL is its corresponding lactone. GHB is converted to GBL via 
intramolecular esterification and GBL is converted to GHB via hydrolysis.66 Fischer 
esterification is a reaction that occurs between an acid and an alcohol. If a compound contains a 
carboxylic acid and a hydroxyl group, then intramolecular esterification takes place and a cyclic 
ester is formed. Hydrolysis is the Fischer esterification reaction in reverse.67 These reactions are 
shown in Figure 19 below. GHB and GBL can be detected in urine by GC-FID and GC-MS.68 
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Figure 19. General esterification and hydrolysis reactions. 
 
GHB must be derivatized with BSTFA + 1% TMCS to be detected by the GC. GBL does 
not need to be derivatized to be detected, but because the matrix is urine and contains water, 
BSTFA + 1% TMCS will also be used for this analysis to derivatize the water. Drug 
concentrations in urine are detected as trace amounts, often at ppb levels. Therefore, 
concentrations in the ng/mL range must be successfully analyzed. Drugs were spiked into a 
human urine sample known to be free of any illegal substances. The interconversion between 
GHB and GBL will also be shown because they are metabolites of one another and will appear in 
a urine sample of a user of either drug.  
Experimental 
Materials 
Methamphetamine sulfate, amphetamine HCl, and GBL were purchased from Sigma-
Aldrich (St. Louis, Missouri). GHB was purchased from Cayman Chemical (Ann Arbor, 
Michigan). All other materials were purchased from suppliers previously referenced in Chapter 
2. 
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Sample Preparation 
Methamphetamine & Amphetamine 
A stock solution of methamphetamine in water was prepared by placing 1 mg of 
methamphetamine powder into a vial along with 1 mL of water for a concentration of 1 mg/mL. 
A stock solution of amphetamine in water was prepared in the same manner. The 
methamphetamine stock solution and amphetamine stock solution were diluted further by 
placing 1 µL of each into 1 mL of water. One mL of clean human urine was placed into a vial 
along with 30 µL of the diluted methamphetamine stock solution and 20 µL of the diluted 
amphetamine stock solution. The final concentrations were 28.1 ng/mL of methamphetamine and 
19.0 ng/mL of amphetamine in water and urine with water making up 2.8% of the solution. This 
mixture was analyzed by placing 2.4 µL of the sample into a 20 mL headspace vial. TFAA was 
used as the derivatization agent for this reaction. After a derivatization time of 50 minutes, the 
SPME fiber was moved to the sample vial where the sample was vaporized by heating to 60℃. 
The fiber was then placed in the inlet of the GC for desorption at 250℃. 
GHB & GBL 
A stock solution of GHB in urine was prepared with a concentration of 8 mg/mL by 
placing 2 mg of GHB powder into a vial along with 250 µL of urine. From this solution, 125 µL 
were placed into a new vial with 375 µL of urine for a concentration of 2 mg/mL. An additional 
sample of GHB in water was prepared with a concentration of 1.5 mg/mL. However, due to an 
instrument failure, this sample stood at room temperature for 72 hours. This sample was then 
used as an impromptu study of GHB/GBL stability and analyzed. 
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A stock solution of GBL in urine was prepared with a concentration of 5 µg/mL by 
placing 2.5 µL of a 1 mg/mL solution of GBL in methanol into a vial. The methanol was 
evaporated and 500 µL of urine was added to the vial.  
GC-MS Parameters 
Ten µL of the GBL solution and 2.4 µL of the GHB solution were each placed into a 
headspace vial for analysis. BSTFA + 1% TMCS was used to derivatize GHB and the water in 
urine. 
The same instrumentation and column that was used for methods in Chapter 1 were also 
utilized for these experiments. 
The GC inlet was set to 250ºC and was in spitless mode. The initial oven temperature was 
60ºC and was held for 1 minute. The temperature was then ramped to 250ºC at 15ºC/min and 
held for 1 minute at the final temperature. The mass transfer line was set to 250ºC and a flow rate 
was kept at 2.5 mL/min. The source was held at 230ºC and the quadrupoles were held at 150ºC. 
The scan parameters were 40-550 m/z. All compounds were identified using the SWGDRUG 
and/or NIST libraries. 
Results and Discussion 
Methamphetamine & Amphetamine in Urine 
Methamphetamine and amphetamine were spiked into urine with concentrations of 28.1 
and 19.0 ng/mL respectively. The fragment ions for methamphetamine-TFA is shown in Figure 
20 and for amphetamine-TFA in Figure 21. 
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           a)              b)     c)               d) 
Figure 20. Mass fragmentation for methamphetamine-TFA a) m/z 69, b) m/z 91, c) m/z 118, and 
d) m/z 154. 
 
 
             a.         b.     c.                d. 
Figure 21. Mass fragmentation for amphetamine-TFA a) m/z 69, b) m/z 91, c) m/z 118, and d) 
m/z 140. 
 
The urine blank analyzed with TFAA is shown in Figure 22 and analyzed with BSTFA + 
1% TMCS is shown in in Figure 23. The urine blank analyzed with BSTFA + 1% TMCS 
displays multiple siloxane peaks. The same sample of urine was used for all analyses. 
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1. TFA 
* = Siloxane 
 
Figure 22. Human urine blank derivatized with TFAA. 
 
 
Figure 23. Human urine blank derivatized with BSTFA + 1% TMCS. 
 
The total ion chromatogram along with the extraction ion profiles for methamphetamine-
TFA and amphetamine-TFA in urine is shown in Figures 24 and 25. 
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1. TFA 
2. Unknown Compound 
3. Methamphetamine-TFA 
* = Siloxane 
 
Figure 24. Stacked chromatograms of methamphetamine in urine TIC (bottom) and 
methamphetamine-TFA EIC (m/z 154, top). 
2 2.5 3 3.5 4 4.5 5 5.5 6 6.5 7
N
o
rm
al
iz
ed
 I
o
n
 C
u
rr
en
t
TIME  (min)
1 *
*
3
2
42 
 
1. TFA 
2. Amphetamine-TFA 
* = Siloxane 
 
Figure 25. Stacked chromatograms of amphetamine in urine TIC (bottom) and amphetamine-
TFA EIC (m/z 140, top). 
 
The mass spectrum for methamphetamine-TFA (m/z 154) is shown in Figure 26 and the 
extracted ion mass spectrum for amphetamine-TFA (140) is shown in Figure 27. 
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Figure 26. Mass spectrum of methamphetamine-TFA (m/z 154) in urine (28.1 ng/mL). 
 
 
Figure 27. Mass spectrum of amphetamine-TFA (m/z 140) in urine (19.0 ng/mL). 
 
GHB & GBL in Urine 
GHB and GBL were spiked into urine with concentrations of 2 mg/mL and 5 µg/mL 
respectively. The mass spectra for GHB-TMS2 and GBL are shown in Figures 7 and 13, 
respectively, in Chapter 1. The TIC and EIC of GHB-TMS2 in urine are shown in Figure 28 
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along with its corresponding mass spectrum in Figure 29. Figure 28 displays a BSTFA peak that 
is likely caused by oversaturated of the fiber with BSTFA. The TIC and EIC of GBL in urine are 
shown in Figure 30 and 31 along with its corresponding mass spectrum in Figure 32. 
 
1. BSTFA 
2. GHB-TMS2 
* = Siloxane 
 
Figure 28. TIC of GHB-TMS2
 in urine (2 mg/mL). 
 
 
Figure 29. Mass spectrum of GHB-TMS2
 in urine. 
 
2 4 6 8 10 12
R
el
at
iv
e 
A
b
u
n
d
an
ce
TIME (min)
1
*
2 *
*
*
*
*
40 90 140 190 240 290
R
el
at
iv
e 
A
b
u
n
d
an
ce
m/z
233
147
73
117
45 
 
Figure 30. TIC of GBL in urine (5 µg/mL). All major peaks are siloxanes. 
 
 
Figure 31. EIC of GBL (m/z 42) in urine (5 µg/mL). 
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Figure 32. Mass spectrum of GBL in urine. 
 
As previously stated, GHB and GBL interconvert into one another. The reaction for the 
conversion of GHB to GBL and the reverse is shown in Figure 33. The TIC of the sample of 
GBL spiked into rum is shown below in Figure 33 The GHB-TMS2 peak is also shown in Figure 
32. The TIC of the sample of GHB in water is shown in Figure 35 along with the GBL ion m/z 
42 EIC.  
Figure 33. Reaction for the conversion of GHB to GBL (from left to right) and GBL to GHB 
(from right to left).  
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Figure 34. TIC of GBL in rum showing GHB-TMS2 converted from GBL. 
 
 
Figure 35. TIC of GHB in water (bottom) and EIC of GBL (m/z 42) (top).  
Conclusion 
Methamphetamine and amphetamine were spiked into human urine and analyzed using a 
TV-SPME GC-MS method. Methamphetamine was spiked into urine with a concentration of 
28.1 ng/mL along with 19.0 ng/mL of amphetamine (the metabolite of methamphetamine). 
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These concentrations were in ppb levels, which are realistic concentrations for methamphetamine 
and amphetamine in the urine of drug users.69 
Compounds detected in the methamphetamine sample were only those of TFA, 
methamphetamine-TFA, and siloxanes. Siloxane peaks are caused from degradation of the 
PDMS/DVB fiber. Methamphetamine-TFA peaks 1 and 2 were both identified as 
methamphetamine-TFA by the SWGDRUG library, however, based on the retention time of 
peak 2 and other samples of methamphetamine analyzed using this method, peak 2 is the 
methamphetamine-TFA peak. Peak 1 is likely a compound with a similar mass spectrum as 
methamphetamine-TFA and therefore the library could not differentiate the two compounds. The 
amphetamine in urine sample contained TFA, amphetamine-TFA, and 2,4-Disocyanato-1-
methyl-benzene. 2,4-Disocyanato-1-methyl-benzene is likely a contaminate. It is a compound 
used to synthesize polyurethane foams and was also found in the urine blank sample.70 
GHB and GBL were also spiked into human urine with concentrations of 2 mg/mL and 5 
µg/mL respectively. GHB and GBL are metabolites of one another and should be analyzed for 
simultaneously. This concentration of GBL in urine was a realistic concentration, however, 2 
mg/mL of GHB in urine is not a realistic sample. A realistic concentration of GHB in urine 
would be around 5 µg/mL, however, this method is not able to detect GHB at these 
concentrations thus far. 
The GHB in urine sample contained BSTFA, siloxanes, and GHB-TMS2. There were no 
other compounds detected. Compounds detected in the GBL in urine sample were only those of 
siloxanes and GBL. The abundance of siloxane peaks in the TIC are likely due to the degradation 
of the SPME fiber.  
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CHAPTER 4. METHOD OPTIMIZATION 
Introduction 
As discussed in Chapter 1, the volume of sample needed to completely vaporize in a TV-
SPME experiment may be calculated using Equation 3. For this work, an extraction temperature 
study was performed for methamphetamine, amphetamine, GHB, and GBL in order to determine 
the optimal vaporization and extraction temperatures for this method. The samples were heated 
in the Gerstel agitator at 60, 80, 100, 120, 140, and 160ºC. The initial temperature of 60ºC was 
chosen because this was the temperature used in prior analyses. As it was also the lowest 
temperature, 60ºC was used to determine the maximum allowed volume of the samples. Each 
sample temperature was analyzed in triplicate and the average peak area was calculated and 
plotted against the extraction temperature. This was done to determine the temperature at which 
the analyte was best detected by the GC. Methamphetamine and amphetamine were analyzed 
underivatized in urine and derivatized with TFAA in methanol. GHB was derivatized in water 
with BSTFA + 1% TMCS.  
A limit of detection (LOD) study was also performed for methamphetamine and 
amphetamine with concentrations ranging from 1000 µg/mL to 50 ng/mL in human urine. This 
range of concentrations was chosen based on realistic concentrations of methamphetamine and 
amphetamine in urine as well as to increase the likelihood of a successful detection.69 The 
extraction temperature used for this study was determined from the previous temperature study 
of methamphetamine-TFA and amphetamine-TFA.  
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Experimental 
Materials  
Methamphetamine sulfate, amphetamine HCl, and GBL were purchased from Sigma-
Aldrich (St. Louis, Missouri). GHB was purchased from Cayman Chemical (Ann Arbor, 
Michigan). TFAA and BSTFA + 1% TMCS were purchased from Thermo Fisher Scientific 
(Waltham, Massachusetts). Polydimethyl siloxane divinylbenzene (PDMS/DVB) SPME fibers, 
65 µm film thickness, were purchased from Supelco (Bellefonte, Pennsylvania). 
Sample Preparation 
Methamphetamine and amphetamine were dissolved in urine and methanol with a 
concentration of 1 mg/mL each. GHB and GBL were dissolved in water with a concentration of 
6 mg/mL and 10 mg/mL, respectively. All urine and water samples used a sample volume of 2.4 
µL and all methanol samples used a sample volume of 24 µL. The PDMS/DVB fiber was first 
exposed to either a vial containing TFAA (for the phenylethylamines) for 10 minutes or a vial 
containing BSFTA + 1% TMCS (for GHB and GBL) for 50 minutes The SPME fiber was then 
inserted into the sample vial for 10 minutes. Sample vials were heated in the agitator at 60, 80, 
100, 120, 140, and 160ºC. The fiber was then inserted into the GC inlet for desorption at 250 ºC. 
A set of vials containing methamphetamine and amphetamine in urine were also analyzed using 
the same method, but without the derivatization step. All sample temperatures were analyzed in 
triplicate for all analytes. 
We also attempted to determine limits of detection for methamphetamine and 
amphetamine in urine. Samples of methamphetamine and amphetamine in urine with 
concentrations of 1000, 500, 100, 10, and 0.05 µg/mL were prepared and analyzed using the 
same method as the 60°C temperature study for the analytes of interest. 
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GC-MS Parameters 
The same instrumentation and column that were used for methods in Chapter 2 were also 
utilized for these experiments. 
The GC inlet was set to 250ºC and was in spitless mode. The initial oven temperature was 
60ºC and was held for 1 minute. The temperature was then ramped to 250ºC at 15ºC/min and 
held for 1 minute at the final temperature. The mass transfer line was set to 250ºC and the flow 
rate of hydrogen carrier gas was kept at 2.5 mL/min. The source was held at 230ºC and the 
quadrupoles were held at 150ºC. The scan parameters were 40-550 m/z. Samples were analyzed 
in scanning mode and extracted ion profiles were used to find the peak area of each sample. All 
compounds were identified using the SWGDRUG and/or NIST libraries. 
Results and Discussion 
Methamphetamine Extraction Temperature Study 
Methamphetamine was analyzed with extraction temperatures ranging from 60ºC - 
160ºC. The figures below display the average peak area for each temperature underivatized in 
urine (Figure 36) and with derivatization in methanol (Figure 37). The area for the underivatized 
compound was found by extracting the m/z 58 ion for methamphetamine for all three samples for 
each temperature. The area for the derivatized compound was found by extracting the m/z 154 
ion for methamphetamine-TFA for all three samples for each temperature. 
52 
 
Figure 36. Average Peak Area vs. Extraction Temperature for underivatized methamphetamine 
in urine (m/z 58). 
 
 
Figure 37. Average Peak Area vs. Extraction Temperature for methamphetamine-TFA in 
methanol (m/z 154). 
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Amphetamine Extraction Temperature Study 
Amphetamine was analyzed in urine without derivatization and in methanol with 
derivatization with extraction temperatures ranging from 60ºC - 160ºC. Figure 38 below displays 
the average peak area for each temperature underivatized in urine. This area was found by 
extracting the m/z 44 ion for amphetamine for all three samples for each temperature. Figure 39. 
shows the average peak area for each temperature derivatized in methanol. This area was found 
by extracting the m/z 140 ion for amphetamine-TFA for all three samples for each temperature.  
Figure 38. Average Peak Area vs. Extraction Temperature for amphetamine in urine (m/z 44). 
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Figure 39. Average Peak Area vs. Extraction Temperature for amphetamine-TFA (m/z 140) in 
methanol. 
 
This study showed that for underivatized methamphetamine in urine, 60°C was the optimal 
extraction temperature. However, for derivatized methamphetamine in methanol, 160°C was the 
optimal extraction temperature. For underivatized amphetamine in urine, 100°C was the optimal 
extraction temperature and for amphetamine-TFA in methanol, 140-160°C was the optimal 
extraction temperature. The peak area for amphetamine-TFA in methanol begins to plateau 
around 140ºC, so it would be sufficient to use this temperature. However, because 
methamphetamine is often found with amphetamine, 160ºC would be preferred. Most 
experiments performed with methamphetamine as the analyte of interest are performed with 
derivatization. 
The difference in the extraction temperatures for underivatized and derivatized 
methamphetamine and amphetamine is likely due to the higher boiling points of the derivatives. 
For example, the retention time difference between methamphetamine and methamphetamine-
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TFA is more than 2 minutes, corresponding to a difference in elution temperature of 27.7ºC for 
the methamphetamine samples and 21.9ºC for the amphetamine sample.  
Methamphetamine and Amphetamine LOD 
An LOD study was attempted for methamphetamine and amphetamine with 
concentrations ranging from 50 ng/mL to 1000 µg/mL in urine. Each concentration was analyzed 
in triplicate. TFAA was used as the derivatization agent for these experiments. The SPME fiber 
stripped on multiple occasions at various temperatures and extraction times. An LOD study was 
not completed due to the fiber damage. TFAA is an effective reagent for the derivatization of 
amines, however, when the sample is water based (e.g. urine), trifluoracetic acid (pKa = 0.3) is 
produced71. This reaction is shown in Figure 40. The production of this acid greatly degrades the 
integrity of the fiber. The harshness of TFAA along with the high temperatures creates a harmful 
environment for the SPME fibers and therefore an extraction temperature of 60°C was used for 
all experiments going forward.  
 
Figure 40. Reaction of TFAA with water to form TFA. 
 
GHB Extraction Temperature Study 
GHB was analyzed in water with extraction temperatures ranging from 60ºC - 160ºC. 
Figure 41 below displays the average peak area for each temperature. This area was found by 
56 
extracting the m/z 233 ion for GHB-TMS2 for all three samples for each temperature. It was 
determined that 120ºC was the optimal temperature for GHB as it had the largest average peak 
area. When accounting for the error of this data, it is possible that extraction temperature does 
not have much effect on GHB. 
 
Figure 41. Average Peak Area vs. Extraction Temperature for GHB-TMS2 (m/z 233). 
 
GBL Extraction Temperature Study 
GBL was spiked into water with a concentration of 10 mg/mL and analyzed with 
extraction temperatures of 60, 80, 100, 120, 140, and 160ºC. Figure 42 below displays average 
peak area for each temperature. The average peak area value was found by extracting the m/z 42 
ion for each sample and taking the average of each temperature triplicate. 
-4
-2
0
2
4
6
8
10
12
14
16
18
20
22
40 60 80 100 120 140 160 180
A
v
er
ag
e 
P
ea
k
 A
re
a
Extraction Temperature (ºC)
57 
 
 
Figure 42. Average Peak Area vs. Extraction Temperature for GBL (m/z 42). 
 
The GHB extraction temperature study showed that 100-120°C was the optimal extraction 
temperature for GHB-TMS2 and 60°C for GBL. Similar issues arise with BSTFA as they do with 
TFAA. While BSTFA is not as harsh for the SPME fibers as TFAA, it still causes them to 
degrade. In addition, GHB requires a 50-minute derivatization time which causes the fibers to 
degrade more quickly. The long derivatization time and high temperatures are not ideal 
conditions for the SPME fiber. Therefore, 60°C was used for future GHB and GBL experiments. 
Conclusion 
Methamphetamine, amphetamine, GHB, and GBL extraction temperature studies were 
performed to determine the optimal extraction temperature at which these analytes would be 
detected by the GC. Extraction temperatures ranging from 60-160°C were utilized. The optimal 
temperatures were determined to be 60°C for methamphetamine, 160°C for methamphetamine-
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TFA, 100°C for amphetamine, 140-160°C for amphetamine-TFA, 100-120°C for GHB, and 
60°C for GBL. Due to the wide range in temperature shown by the error bars, these studies 
should be performed again to verify these optimal temperatures.  
An LOD study was attempted for methamphetamine and amphetamine with concentrations 
ranging from 50 ng/mL to 1000 µg/mL in urine with TFAA as the derivatization agent. As 
stated, when TFAA reacts with a water-based solvent, trifluoracetic acid is produced. The 
production of this acid causes the SPME fiber to swell and break or causes the coating to strip 
away more easily. This study was analyzing 6 varying concentrations in triplicate for a total of 
18 samples. Therefore, the fiber could not handle the acid production and broke or stripped 
during each attempt of this study. Therefore, the LOD study of methamphetamine and 
amphetamine was not completed. 
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CHAPTER 5. FUTURE WORK 
Powder Samples 
 It was previously determined that powder samples may also be identified using the TV-
SPME method.1 While the use of the TV-SPME technique to analyze solid samples will not 
technically be a total vaporization method, the same method parameters used in TV-SPME will 
be utilized. A sample of a powder or a powder mixture will be placed into a GC headspace vial 
without any sample preparation. This will be done with pure samples, mixtures, and street 
samples obtained from a local law enforcement agency. Samples that will be analyzed include: 
1) methamphetamine, pseudoephedrine and caffeine 
2) cocaine, procaine and inositol 
3) heroin, diphenhydramine and fentanyl 
4) ethylpentylone and caffeine 
5) tablets including hydrocodone, oxycodone, and hydromorphone  
These mixtures have been suggested by Donna Roskowski, a former drug chemist for the Indiana 
State Police.  
 These samples will be analyzed using variants of the original TV-SPME method. 
Samples will be analyzed both underivatized and derivatized when necessary. Derivatization will 
be done by exposing the SPME fiber to the vapor of the derivatization agent as well as 
immersing the fiber into an organic solution of the derivatization agent. Exposing the SPME 
fiber to a solvent such as acetonitrile prior to the solid drug sample will also be performed to 
determine if the solvent on the fiber helps to adsorb the solid sample. A summary of successful 
methods and the analyte completed thus far are shown in Table 3. To date, methamphetamine 
and caffeine in powder form have been analyzed utilizing this method. Solid caffeine and solid 
60 
methamphetamine were analyzed using a PDMS/DVB fiber. Solid caffeine and solid 
methamphetamine were each placed into a 20 mL headspace vial and analyzed at 60°C with a 
10-minute extraction time. Methamphetamine was analyzed with and without derivatization. 
Both methamphetamine samples had an extraction temperature of 120°C. Methamphetamine was 
derivatized with TFAA for 10-minutes to form methamphetamine-TFA. The chromatograms for 
these compounds are shown in Figures 43-45 below. 
Table 3. Summary of successful methods and analytes. 
 Headspace of Solid 
Sample 
TV-SPME of 
Sample in Solvent 
TV-SPME of 
Sample in Urine 
Underivatized Caffeine 
Pseudoephedrine 
Amphetamine 
Methamphetamine 
GBL 
Amphetamine 
Methamphetamine 
GBL* 
Derivatized  Amphetamine 
Methamphetamine 
GHB 
Amphetamine* 
Methamphetamine* 
GHB 
*Trace concentrations  
 
 
Figure 43. Underivatized solid methamphetamine. 
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* = Siloxane 
Figure 44. Derivatized solid methamphetamine. 
 
 
1. Caffeine 
2. Hexadecanoic acid-TMS 
* = Siloxane 
Figure 45. TIC of caffeine powder with TV-SPME method.  
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Plant Material 
 Green leafy plant material (GLPM) is one of the most common pieces of evidence 
submitted to crime laboratories.72 GLPM is often determined to be marijuana through 
microscopic and macroscopic identification as well as other chemical testing methods that must 
be performed manually.73 The identification of these exhibits must be done individually and are 
therefore time consuming. With this automated SPME method, multiple samples may be 
analyzed in sequence. For example, a sample of tetrahydrocannabinol and a sample of 
cannabidiol may be analyzed within the same automated sequence because they require the same 
method parameters. 
Future work will include the analysis of naturally occurring compounds found in marijuana 
including tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN) “as is” and 
derivatized with BSTFA + 1% TMCS. Synthetic cannabinoids that will also be analyzed with 
and without derivatization will include 5-fluoro-ADB, FUB-AMB, and fluoro-MDMB-PICA. 
These synthetic cannabinoids will be derivatized with BSTFA + 1% TMCS. The analyses of 
these compound will be performed in the same way as the powder substances.  
Toxicological Samples 
 Previous experiments involving drugs in biological samples included methamphetamine, 
amphetamine, THC-COOH, benzoylecgonine, GHB, and GBL in urine. THC-COOH is the 
metabolite of THC and benzoylecgonine is the metabolite of cocaine. Realistic concentrations of 
these samples are at ppb levels. GBL, methamphetamine, and amphetamine in urine were 
successfully detected at these concentrations. However, GHB, THC-COOH, and 
benzoylecgonine could not be detected.  
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Future work will include making various changes to the methodology to detect these 
compounds at ppb concentrations. Various temperatures (>100°C) and derivatization agents will 
be utilized including butyl chloroformate. Butyl chloroformate has successfully derivatized 
methamphetamine in acetonitrile when a 10-minute derivatization time was used. The resulting 
chromatogram is shown in Figure 48 and the mass spectrum is shown in Figure 49. Butyl 
chloroformate is not has harsh on the SPME fibers as TFAA and therefore higher temperatures 
may be used. The general reaction for butyl chloroformate with an amine is shown in Figure 46. 
The butyl chloroformate derivative of methamphetamine is shown in Figure 47. This 
derivatization agent will be used to identify methamphetamine and amphetamine in urine at ppb 
levels. THC-COOH and benzoylecgonine will be analyzed using BSTFA + 1% TMCS as the 
derivatization agent. Various derivatization times (5-60 minutes) and temperatures (>100°C) will 
be used to detect these compounds in urine.  
Figure 46. General reaction of an amine with butyl chloroformate. 
 
 
Figure 47. The butyl chloroformate derivative of methamphetamine.  
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Figure 48. TIC for methamphetamine in acetonitrile derivatized with butyl chloroformate  
(1 mg/mL).  
 
 
Figure 49. Mass spectrum for methamphetamine in acetonitrile derivatized with butyl 
chloroformate (1 mg/mL).  
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The mass fragments for methamphetamine derivatized with butyl chloroformate are shown in 
Figure 50.  
 
 
 
 
 
         (a)          (b)  
Figure 50. Mass fragments a) m/z 91 and b) m/z 158 for methamphetamine derivatized with 
butyl chloroformate. 
 
Once these drugs have successfully been detected in urine, additional biological samples 
including blood or plasma and saliva will be spiked with realistic concentrations of these drugs 
and analyzed using the TV-SPME method.   
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